With a large accumulation of experience in the clinical application of genetically recombinant human growth hormone (rhGH), the number of diseases approved for treatment with rhGH is gradually increasing, so what conditions can be treated with growth hormone (rhGH) for dwarfism? 1.Growth hormone deficiency (GHD): In 1985, the US FDA approved rhGH for the treatment of growth hormone deficiency, which is the indication with the best effect of applying growth hormone. The clinical application at home and abroad for many years shows that recombinant human growth hormone can make these children with dwarfism generally grow 10-12cm per year. 2. idiopathic dwarfism (ISS): In 2003, the US FDA approved the application of growth hormone treatment for idiopathic dwarfism (familial dwarfism) to improve the final height of patients. The application of growth hormone to these children has been observed, and more satisfactory results have been achieved. 3. Short stature caused by congenital ovarian dysplasia (Turner’s syndrome), chronic renal insufficiency and intrauterine growth retardation has also been recognized as an indication for growth hormone therapy. 4. Growth hormone treatment is also effective for familial dwarfism, delayed height development caused by precocious puberty, and chondrodysplasia. Whether your child can be treated with growth hormone must be used under the guidance of a doctor, and it is recommended to visit the Department of Pediatric Endocrinology or the Department of Growth and Development of a regular hospital.